NCT03875560View on ClinicalTrials.gov

IC14 in Adult Patients With Dengue Fever

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

June 30, 2020

Conditions
Dengue Fever
Interventions
BIOLOGICAL

IC14

recombinant chimeric anti-human CD14 monoclonal antibody

DRUG

Placebo

Inactive

Sponsors
All Listed Sponsors
lead

Implicit Bioscience

INDUSTRY